Koninklijke Philips N.V. NY Reg (PHG) Stock Analysis

Q: What is the PHG stock price target?

Take-profit $29.35 (+12.7% upside). Prior stop was $24.60.

Q: What are the risks of investing in PHG?

Earnings in 6 days (event risk); Negative momentum; Momentum score 1.3/10 — below 4.5 minimum; EARNINGS_PROXIMITY:6d<=7d.

Q: Is PHG overvalued or undervalued?

Koninklijke Philips N.V. NY Reg trades at a P/E of 23.5 (forward 12.5). TrendMatrix value score: 7.4/10. Overall verdict: Sell.

Q: What do analysts say about PHG?

30 analysts cover PHG with a consensus score of 3.7/5. Average price target: $34.

SellModerate ConfidenceUpdated 2026-04-30

Healthcare · Medical Devices

Earnings in 6 days (2026-05-06). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

$26.14+12.7% A.UpsideScore 5.3/10#24 of 40 Medical Devices

Stop $24.60Target $29.35(analyst − 13%)A.R:R 2.3:1

Analyst target$33.74+29.1%5 analysts

$29.35our TP

$26.14price

$33.74mean

$41

Sell if holding. Momentum 1.3/10 is below the 5.0 floor at $26.14 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Earnings in 6 days (event risk). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.3/10, moderate confidence.

Passes 5/7 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on weak momentum and earnings proximity 6d<=7d. Suitability: moderate.

Thesis

Rewards

Strong earnings beat streak (4/4)

Attractive valuation

Risks

Earnings in 6 days (event risk)

Negative momentum

Key Metrics

P/E (TTM)23.5

P/E (Fwd)12.5

Mkt Cap$24.3B

EV/EBITDA14.7

Profit Mgn5.0%

ROE7.8%

Rev Growth1.1%

Beta0.96

Dividend3.96%

Rating analysts30

Quality Signals

Piotroski F8/9

Options Flow

P/C0.54bullish

IV78%elevated

Max Pain$20-23.5% vs spot

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers

Overall = weighted sum of the 10 dimension scores. Fundamentals (Value/Quality/Growth) carry 45%; market signals (Momentum/Sentiment/Insider/Peer) carry 40%; structure (Technical/Risk/Catalyst) carries 15%.

DimensionScoreWeightContribution

Value7.415%1.11

Quality4.415%0.66

Growth6.415%0.96

Momentum1.310%0.13

Sentiment6.010%0.60

Insider Activity5.010%0.50

Peer Rank3.110%0.31

Technical Setup7.05%0.35

Risk Profile5.95%0.30

Catalyst8.05%0.40

Overall (Σ contributions)5.31

Small float-rounding may cause last-digit differences between this sum and the displayed Overall.

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd

0.0

Volume

0.0

Obv

1.0

Ma Position

2.2

Rsi

3.5

Volume distribution (falling OBV)Below 200-MA but MA still rising (+2.2%/30d) — pullback in uptrend, not confirmed weakness

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank

1.0

Quality Rank

4.7

Value Rank

6.6

GatesMomentum 1.3<4.5EARNINGS PROXIMITY 6d<=7dA.R:R 2.3 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARSuitability: Moderate

RSI

34 · Neutral

↓ 20D MA↓ 50D MA↓ 200D MAGOLDEN CROSSSupport $25.10Resistance $29.95

Price Targets

$25

$29

A.Upside+12.3%

A.R:R2.3:1

Position Sizing

ConvictionNone

Suggested %0.5%

Max %1%

RegimeSteady

Risk Alerts

! Momentum score 1.3/10 — below 4.5 minimum

! EARNINGS_PROXIMITY:6d<=7d

Earnings

4/4 beats

Next Earnings2026-05-06 (6d)

Verdict History

reverse chrono — latest first

Loading history...

Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.

Frequently Asked Questions

Is PHG stock a buy right now?

Sell if holding. Momentum 1.3/10 is below the 5.0 floor at $26.14 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Earnings in 6 days (event risk). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $24.60. Score 5.3/10, moderate confidence.

What is the PHG stock price target?

Take-profit target: $29.35 (+12.7% upside). Prior stop was $24.60. Stop-loss: $24.60.

What are the risks of investing in PHG?

Earnings in 6 days (event risk); Negative momentum.

Is PHG overvalued or undervalued?

Koninklijke Philips N.V. NY Reg trades at a P/E of 23.5 (forward 12.5). TrendMatrix value score: 7.4/10. Verdict: Sell.

What do analysts say about PHG?

30 analysts cover PHG with a consensus score of 3.7/5. Average price target: $34.

What does Koninklijke Philips N.V. NY Reg do?Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and...

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.